Coloplast AS 

€0
0
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12MayExpected
Q4 2025
Next
0.79
0.8
0.82
0.84
Expected EPS
0.7864134002400001
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CBHD.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Baxter International
BAX
Mkt Cap8.61B
Baxter International Inc. offers a range of medical devices and services that compete directly with Coloplast's offerings in the continence and critical care sectors.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc provides medical devices and technologies in areas overlapping with Coloplast's, including urology and pelvic health.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation competes in the medical devices sector, particularly in areas of urology and pelvic health, similar to Coloplast.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. is involved in women's health, diagnostics, and surgical products, competing with Coloplast in the healthcare solutions sector.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew plc provides advanced wound care, orthopedics, and other medical devices, competing with Coloplast in the wound care market.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson operates in the healthcare sector, offering products through its medical devices division that compete with Coloplast's offerings in wound care and surgery.
Cooper Companies
COO
Mkt Cap13.69B
The Cooper Companies, Inc. is focused on contact lens and women's health, indirectly competing with Coloplast in the healthcare market.
Procter & Gamble
PG
Mkt Cap334.97B
Procter & Gamble Co., through its healthcare segment, offers products that can compete with Coloplast, especially in the personal healthcare and incontinence product lines.
Stryker
SYK
Mkt Cap126.97B
Stryker Corporation is a medical technologies firm with products in orthopaedics, surgery, and neurotechnology, indirectly competing with Coloplast in the healthcare solutions sector.

About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Mr. Lars Soren Rasmussen Ph.D.
Employees
16983
Country
Denmark
ISIN
DK0060448595

Listings

0 Comments

Share your thoughts

FAQ

What is Coloplast AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Coloplast AS stocks are traded under the ticker CBHD.MU.
When is the next Coloplast AS earnings date?
Coloplast AS is going to release the next earnings report on May 12, 2026.
What were Coloplast AS earnings last quarter?
CBHD.MU earnings for the last quarter are 0.84 EUR per share, whereas the estimation was 0.81 EUR resulting in a +3.46% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Coloplast AS have?
As of April 12, 2026, the company has 16,983 employees.
In which sector is Coloplast AS located?
Coloplast AS operates in the Health & Wellness sector.
When did Coloplast AS complete a stock split?
Coloplast AS has not had any recent stock splits.
Where is Coloplast AS headquartered?
Coloplast AS is headquartered in Humlebæk, Denmark.